Literature DB >> 2483503

Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins.

K Kuwano1, T J Braciale, F A Ennis.   

Abstract

A cross-reactive cytotoxic T lymphocyte clone was produced by stimulation with a hybrid protein that contained a portion of the NS1 and the HA2 subunit of A/PR/8/34 (H1N1) virus. Transfer of this clone clears virus from the lungs of mice challenged with H1 or H2 viruses. In these experiments we define the location of the protective CTL epitope to the transmembrane portion of the influenza A virus hemagglutinin which is well-conserved on H1 and H2 subtype viruses. The H1 and H2 cross-reactive CTL clone recognized a synthetic peptide of 23 amino acids (anchor peptide) corresponding to the transmembrane domain of the A/PR/8 (H1) HA as well as the comparable anchor peptide of the A/JAP (H2) HA. The anchor peptide of the A/PR/8 HA competed against the anchor peptide of A/JAP HA in cold target inhibition tests. These results indicate that the epitope recognized by the cross-reactive CTL is located on the transmembrane region of both A/PR/8 HA and A/JAP HA. We prepared synthetic peptides to define the epitope within the transmembrane region of A/PR/8 HA which is recognized by a cross reactive CTL clone. The results indicate that residues 518-528 in the transmembrane region of A/PR/8 HA contain the cross-reactive CTL epitope.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2483503     DOI: 10.1089/vim.1989.2.163

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  11 in total

1.  Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice.

Authors:  W Gerhard; A M Haberman; P A Scherle; A H Taylor; G Palladino; A J Caton
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  Overlapping cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5 hemagglutinin.

Authors:  C E Hioe; N Dybdahl-Sissoko; M Philpott; V S Hinshaw
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine.

Authors:  Mary Dawn T Co; Laura Orphin; John Cruz; Pamela Pazoles; Alan L Rothman; Francis A Ennis; Masanori Terajima
Journal:  Vaccine       Date:  2008-02-26       Impact factor: 3.641

4.  Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1-specific, H2-specific, and H1- and H2-cross-reactive murine cytotoxic T-lymphocyte clones.

Authors:  M Tamura; K Kuwano; I Kurane; F A Ennis
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

5.  Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin.

Authors:  K G Gould; H Scotney; G G Brownlee
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

6.  GM-CSF in the lung protects against lethal influenza infection.

Authors:  Fang-Fang Huang; Peter F Barnes; Yan Feng; Ruben Donis; Zissis C Chroneos; Steven Idell; Timothy Allen; Daniel R Perez; Jeffrey A Whitsett; Kyri Dunussi-Joannopoulos; Homayoun Shams
Journal:  Am J Respir Crit Care Med       Date:  2011-04-07       Impact factor: 21.405

7.  Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.

Authors:  Behazine Combadière; Annika Vogt; Brice Mahé; Dominique Costagliola; Sabrina Hadam; Olivia Bonduelle; Wolfram Sterry; Shlomo Staszewski; Hans Schaefer; Sylvie van der Werf; Christine Katlama; Brigitte Autran; Ulrike Blume-Peytavi
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

8.  In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses.

Authors:  Mary Dawn T Co; Laura Orphin; John Cruz; Pamela Pazoles; Karin M Green; James Potts; Anita M Leporati; Jenny Aurielle B Babon; James E Evans; Francis A Ennis; Masanori Terajima
Journal:  Vaccine       Date:  2008-10-31       Impact factor: 3.641

9.  The canine MHC class Ia allele DLA-88*508:01 presents diverse self- and canine distemper virus-origin peptides of varying length that have a conserved binding motif.

Authors:  Peter Ross; Paige S Nemec; Alexander Kapatos; Keith R Miller; Jennifer C Holmes; Steven E Suter; Adam S Buntzman; Erik J Soderblom; Edward J Collins; Paul R Hess
Journal:  Vet Immunol Immunopathol       Date:  2018-02-02       Impact factor: 2.046

10.  Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors.

Authors:  Jessica B Lee; Mathias Oelke; Lakshmi Ramachandra; David H Canaday; Jonathan P Schneck
Journal:  Immun Ageing       Date:  2011-08-16       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.